The largest database of trusted experimental protocols

Brdu incorporation assay

Manufactured by Abcam
Sourced in United States

The BrdU incorporation assay is a laboratory technique used to measure cell proliferation by detecting the incorporation of the thymidine analog bromodeoxyuridine (BrdU) into newly synthesized DNA during the S phase of the cell cycle. This assay provides a quantitative assessment of active cell division.

Automatically generated - may contain errors

4 protocols using brdu incorporation assay

1

BrdU Assay for AML Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bromodeoxyuridine (BrdU) incorporation assay (Abcam, USA) performed to detected DNA synthesis ability of AML cells according to the manufacturer’s instructions. In brief, cells were seeded into 6‐well plates and treated with the stimulus for forty-eight hours. BrdU solution (10 μM) was incubated for 2 h and washed with PBS. Cells were fixed with paraformaldehyde for 30 min, followed with Triton X-100 for 15 min. After, cells were treated with BrdU detection antibody (1:1000, ThermoFisher, China) at 4 °C for overnight. Cells were washed with ice-cold PBS for three times. Secondary antibodies which were incubated for 2 h. DAPI was treated for staining of cell nuclear. At last, cells were examined by fluorescence microscopy (Olympus, Japan) with the Image-Pro Plus software (Olympus). Each experiment was performed three times.
+ Open protocol
+ Expand
2

Proliferation Analysis of Subconfluent Stromal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proliferative activity of subconfluent sl-pHCs was determined with regard to distribution in the cell cycle and population doubling time (PDT). The cells were stained with Muse® Cell Cycle Kit and Muse® Count and Viability Kit, respectively. The analysis was performed on Muse Cell Analyzer – the reagents and analyser derived from Luminex/Merck (Poznan, Poland). The number of cells was determined routinely, and obtained data were used to calculate PDT with an algorithm published by Heuer et al. [11 (link)] and Cell Calculator [12 ]. The proliferation of sl-pHCs was also evaluated based on the BrdU incorporation assay (Abcam, Symbios, Straszyn, Polska). For BrdU analysis, cells were seeded at density 2.5 × 103on a 96-well plate. All tests were performed accordingly to well-described methods [8 (link), 13 (link)] and in compliance with protocols provided by the manufacturers of the assays. Furthermore, colony-forming unit (CFU-E) occurrence efficiency was assessed after ten days of culture using the earlier protocol for stromal [8 (link)] and cancer cells [14 (link)].
+ Open protocol
+ Expand
3

BrdU Proliferation Assay for HTR-8/SVneo Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Detection of BrdU incorporation into HTR-8/SVneo cells to evaluate cell proliferation based on BrdU incorporation assay (Abcam). The cells were placed on 96-well plates (5 × 103 cells per well) and incubated for 24 h, then 10 M BrdU was added for another 15 h. The cells were then immobilized for 30 min and incubated with 100 μL of BrdU for 60 min. After incubating with 100 μL IgG for 30 min, 100 μL TMB substrate was added and incubated in darkness at room temperature for 30 min. Cell proliferation was evaluated at 450 nm using a microplate reader.
+ Open protocol
+ Expand
4

Exosome-induced Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A bromodeoxyuridine (BrdU)-incorporation assay (Abcam) was used to measure cell proliferation after treatment of HEMEC with HULM-derived exosomes, UTSM-derived exosomes, or PBS as a control. A total of 1 × 105 cells per well were plated in a 96-well plate, then treated with exosomes or PBS for 48 h. BrdU incorporation was allowed to proceed for 4 h at 37 °C, followed by DNA denaturation, BrdU antibody labeling, and detection at 492 nm/370 nm absorbance using the Synergy HT plate reader (BioTek Instruments Inc., Winooski, VT, USA). BrdU incorporation was then quantified to compare cells treated with HULM-derived exosomes versus UTSM-derived exosomes, using PBS as a negative control; the final absorbance was calculated by subtracting the absorbance at 492 nm from the absorbance at 370 nm. The assay was performed four times with triplicate samples each run.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!